Wells Fargo & Company 4 D Molecular Therapeutics, Inc. Transaction History

Wells Fargo & Company

$429 Billion
Q1 2025

A detailed history of Wells Fargo & Company transactions in 4 D Molecular Therapeutics, Inc. stock. As of the latest transaction made, Wells Fargo & Company holds 23,654 shares of FDMT stock, worth $91,777. This represents 0.0% of its overall portfolio holdings.

Number of Shares

23,654

Previous 25,852 8.5%

Holding current value

$91,777

Previous $143,000 46.85%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 13, 2025	SELL	$3.23 - $6.6 $7,099 - $14,506	-2,198 Reduced 8.5%	23,654 $76,000
Q4 2024 Feb 12, 2025	BUY	$5.3 - $10.41 $39,553 - $77,689	7,463 Added 40.58%	25,852 $143,000
Q3 2024 Nov 13, 2024	BUY	$10.81 - $27.22 $1,556 - $3,919	144 Added 0.79%	18,389 $198,000
Q2 2024 Aug 13, 2024	BUY	$20.93 - $30.01 $81,627 - $117,039	3,900 Added 27.19%	18,245 $382,000
Q1 2024 May 10, 2024	BUY	$17.03 - $35.87 $35,269 - $74,286	2,071 Added 16.87%	14,345 $457,000
Q4 2023 Feb 09, 2024	SELL	$9.76 - $21.25 $193,452 - $421,196	-19,821 Reduced 61.76%	12,274 $248,000
Q3 2023 Nov 13, 2023	SELL	$12.64 - $19.76 $88,328 - $138,082	-6,988 Reduced 17.88%	32,095 $408,000
Q2 2023 Aug 15, 2023	BUY	$15.16 - $23.26 $168,200 - $258,069	11,095 Added 39.64%	39,083 $706,000
Q1 2023 May 12, 2023	BUY	$15.45 - $23.19 $429,324 - $644,403	27,788 Added 13894.0%	27,988 $481,000
Q4 2022 Feb 13, 2023	SELL	$6.85 - $25.46 $472 - $1,756	-69 Reduced 25.65%	200 $4,000
Q3 2022 Nov 14, 2022	SELL	$6.96 - $11.48 $1,941 - $3,202	-279 Reduced 50.91%	269 $3,000
Q2 2022 Aug 12, 2022	SELL	$5.68 - $15.99 $59,816 - $168,390	-10,531 Reduced 95.05%	548 $3,000
Q1 2022 May 16, 2022	SELL	$13.16 - $22.64 $120,479 - $207,269	-9,155 Reduced 45.25%	11,079 $168,000
Q4 2021 Feb 14, 2022	BUY	$19.56 - $32.94 $245,477 - $413,397	12,550 Added 163.33%	20,234 $444,000
Q3 2021 Nov 15, 2021	BUY	$22.73 - $36.04 $155,905 - $247,198	6,859 Added 831.39%	7,684 $206,000
Q2 2021 Aug 16, 2021	SELL	$22.2 - $42.29 $35,853 - $68,298	-1,615 Reduced 66.19%	825 $20,000
Q1 2021 May 13, 2021	BUY	$35.94 - $52.67 $87,693 - $128,514	2,440 New	2,440 $106,000

Others Institutions Holding FDMT

# of Institutions

128

Shares Held

43.5M

Call Options Held

25.8K

Put Options Held

33.4K

View Full List

About 4D Molecular Therapeutics, Inc.

Ticker FDMT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 32,382,400
Market Cap $126M
Description
4D Molecular Therapeutics, Inc., a clinical-stage gene therapy company, develops product candidates using its adeno-associated viruses vectors. It develops a portfolio of gene therapy product candidates focuses in three therapeutic areas: ophthalmology, cardiology, and pulmonology. The company has three product candidates that are in clinical tr...

More about FDMT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.

Account

Wells Fargo & Company 4 D Molecular Therapeutics, Inc. Transaction History